Evolution of the Average Target: Lipocine Inc.

Evolution of the Target Price: Lipocine Inc.

Changes in Analyst Recommendations: Lipocine Inc.

1dd25ab03d5aa97.joGPUIL1LK_5wgj4AxgM39TyzwLn80qAZFnsoXAcUFk.-vfXE8S-c_-clEmnV19pt4abvk2dpXjjNG7b9CV3J2_RyNY0w7Qb2rf7RQ~01b2fe56ab700446eadfecc94fc52bf8

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +127.27%
+11.79%
+21.92%
+19.64%
+7.4%
+25.43%
+18.27%
+50.7%
+3.91%
+73.24%
Average +35.96%
Weighted average by Cap. +22.17%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.070USD
Average target price
5.000USD
Spread / Average Target
+141.55%
High Price Target
6.000USD
Spread / Highest target
+189.86%
Low Price Target
4.000USD
Spread / Lowest Target
+93.24%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. LPCN Stock
  4. Consensus Lipocine Inc.